azelaic acid and erythromycin

azelaic acid has been researched along with erythromycin in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Auld, J	1
Purdy, S	2
Melnik, BC; Schmitz, G; Zouboulis, CC	1
Ajami, M; Babakoohi, S; Firooz, A; Habibey, R; Nassiri-Kashani, M; Pazoki-Toroudi, H; Rahshenas, M; Shizarpour, M; Tabatabaie, H	1
Degitz, K; Fluhr, JW	1
Melnik, BC; Schmitz, G	1
Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H	1

Reviews

6 review(s) available for azelaic acid and erythromycin

Article	Year
Topical therapy of acne. The Australasian journal of dermatology, 1986, Volume: 27, Issue:3 Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Dicarboxylic Acids; Erythromycin; Humans; Miconazole; Oxytetracycline; Salicylates; Salicylic Acid; Tretinoin	1986
Acne vulgaris. Clinical evidence, 2005, Issue:13 Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Drug Therapy, Combination; Erythromycin; Humans; Isotretinoin; Naphthalenes; Tetracycline; Tretinoin; Zinc	2005
Acne vulgaris. Clinical evidence, 2006, Issue:15 Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythromycin; Humans; Isotretinoin; Minocycline; Naphthalenes; Tetracycline; Tretinoin; Zinc	2006
Anti-acne agents attenuate FGFR2 signal transduction in acne. The Journal of investigative dermatology, 2009, Volume: 129, Issue:8 Topics: Acne Vulgaris; alpha-MSH; Androgen Antagonists; Benzoyl Peroxide; Dicarboxylic Acids; Erythromycin; Humans; Interleukin-1alpha; Isotretinoin; Reactive Oxygen Species; Receptor, ErbB-2; Signal Transduction; Tetracyclines; Tretinoin	2009
[Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010, Volume: 8 Suppl 1 Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Pregnancy; Randomized Controlled Trials as Topic; Tetracyclines	2010
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. The Cochrane database of systematic reviews, 2020, 05-01, Volume: 5 Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Erythromycin; Female; Glycolates; Humans; Keratolytic Agents; Male; Mandelic Acids; Niacinamide; Patient Dropouts; Pyruvic Acid; Quality of Life; Salicylic Acid; Sulfur; Tretinoin; Young Adult; Zinc	2020

Trials

1 trial(s) available for azelaic acid and erythromycin

Article	Year
Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. The Journal of dermatological treatment, 2010, Volume: 21, Issue:3 Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Humans; Male; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult	2010

Article

Year

Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.

The Journal of dermatological treatment, 2010, Volume: 21, Issue:3

Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Humans; Male; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult

2010

Other Studies

2 other study(ies) available for azelaic acid and erythromycin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? Experimental dermatology, 2013, Volume: 22, Issue:7 Topics: Acne Vulgaris; AMP-Activated Protein Kinases; Benzoyl Peroxide; Dermatologic Agents; Dicarboxylic Acids; Enzyme Activation; Erythromycin; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Isotretinoin; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Oxidative Stress; Tetracycline; TOR Serine-Threonine Kinases; Up-Regulation	2013

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1?

Experimental dermatology, 2013, Volume: 22, Issue:7

Topics: Acne Vulgaris; AMP-Activated Protein Kinases; Benzoyl Peroxide; Dermatologic Agents; Dicarboxylic Acids; Enzyme Activation; Erythromycin; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Isotretinoin; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Oxidative Stress; Tetracycline; TOR Serine-Threonine Kinases; Up-Regulation

2013